News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
393,414 Results
Type
Article (46883)
Company Profile (78)
Press Release (346453)
Multimedia
Podcasts (19)
Webinars (10)
Section
Business (112221)
Career Advice (1299)
Deals (15347)
Drug Delivery (43)
Drug Development (48463)
Employer Resources (92)
FDA (7475)
Job Trends (8713)
News (183041)
Policy (14067)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Biotech Bay Standard (3)
2024 Biotech Beach Digital (3)
2024 Genetown Standard (2)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (1)
2024 Pharm Country Standard (3)
2025 Lone Star Bio Digital (2)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2603)
Academic (1)
Accelerated approval (4)
Adcomms (6)
Allergies (44)
Alliances (32682)
ALS (64)
Alzheimer's disease (1134)
Antibody-drug conjugate (ADC) (75)
Approvals (7516)
Artificial intelligence (171)
Autoimmune disease (11)
Automation (7)
Bankruptcy (87)
Best Places to Work (6897)
BIOSECURE Act (10)
Biosimilars (27)
Biotechnology (51)
Bladder cancer (36)
Brain cancer (21)
Breast cancer (169)
Cancer (1492)
Cardiovascular disease (89)
Career advice (1085)
Career pathing (21)
CAR-T (100)
Cell therapy (258)
Cervical cancer (10)
Clinical research (37829)
Collaboration (613)
Compensation (69)
Complete response letters (6)
COVID-19 (1849)
CRISPR (29)
C-suite (123)
Cystic fibrosis (65)
Data (1465)
Decentralized trials (2)
Denatured (8)
Depression (28)
Diabetes (139)
Diagnostics (3710)
Digital health (10)
Diversity (4)
Diversity, equity & inclusion (24)
Drug discovery (95)
Drug pricing (46)
Drug shortages (6)
Duchenne muscular dystrophy (48)
Earnings (41803)
Editorial (20)
Employer branding (14)
Employer resources (80)
Events (47946)
Executive appointments (410)
FDA (8131)
Featured Employer (21)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (5)
Funding (466)
Gene editing (59)
Generative AI (15)
Gene therapy (187)
GLP-1 (391)
Government (2214)
Grass and pollen (2)
Guidances (32)
Healthcare (10587)
Huntington's disease (10)
IgA nephropathy (7)
Immunology and inflammation (51)
Indications (19)
Infectious disease (1936)
Inflammatory bowel disease (88)
Inflation Reduction Act (4)
Influenza (39)
Intellectual property (54)
Interviews (261)
IPO (7409)
IRA (26)
Job creations (2114)
Job search strategy (937)
Kidney cancer (6)
Labor market (23)
Layoffs (242)
Leadership (8)
Legal (2397)
Liver cancer (34)
Lung cancer (211)
Lymphoma (104)
Machine learning (5)
Management (28)
Manufacturing (160)
MASH (47)
Medical device (5676)
Medtech (5678)
Mergers & acquisitions (8255)
Metabolic disorders (336)
Multiple sclerosis (51)
NASH (11)
Neurodegenerative disease (50)
Neuropsychiatric disorders (10)
Neuroscience (1479)
NextGen: Class of 2025 (3261)
Non-profit (3560)
Northern California (1428)
Now hiring (24)
Obesity (149)
Opinion (136)
Ovarian cancer (59)
Pain (41)
Pancreatic cancer (50)
Parkinson's disease (101)
Partnered (16)
Patents (115)
Patient recruitment (65)
Peanut (26)
People (32124)
Pharmaceutical (20)
Pharmacy benefit managers (4)
Phase I (11912)
Phase II (16127)
Phase III (12716)
Pipeline (868)
Policy (74)
Postmarket research (1811)
Preclinical (6669)
Press Release (65)
Prostate cancer (64)
Psychedelics (20)
Radiopharmaceuticals (158)
Rare diseases (198)
Real estate (3671)
Recruiting (35)
Regulatory (10551)
Reports (28)
Research institute (2502)
Resumes & cover letters (186)
RNA editing (1)
RSV (20)
Schizophrenia (49)
Series A (68)
Series B (35)
Service/supplier (10)
Sickle cell disease (35)
Southern California (1237)
Special edition (12)
Spinal muscular atrophy (103)
Sponsored (22)
Startups (2130)
Stomach cancer (3)
Supply chain (27)
Tariffs (13)
The Weekly (11)
United States (12510)
Vaccines (459)
Venture capitalists (13)
Weight loss (77)
Women's health (15)
Worklife (8)
Date
Today (36)
Last 7 days (381)
Last 30 days (1357)
Last 365 days (18948)
2025 (5637)
2024 (20306)
2023 (23585)
2022 (33090)
2021 (34799)
2020 (31746)
2019 (25963)
2018 (19479)
2017 (18647)
2016 (18613)
2015 (22121)
2014 (16671)
2013 (14792)
2012 (14723)
2011 (15401)
2010 (14288)
Location
Africa (536)
Alabama (43)
Alaska (3)
Arizona (84)
Arkansas (4)
Asia (24232)
Australia (4648)
California (3207)
Canada (1168)
China (301)
Colorado (130)
Connecticut (154)
Delaware (70)
Europe (57446)
Florida (524)
Georgia (114)
Idaho (21)
Illinois (269)
India (23)
Indiana (185)
Iowa (7)
Japan (120)
Kansas (44)
Kentucky (11)
Louisiana (4)
Maine (18)
Maryland (478)
Massachusetts (2348)
Michigan (135)
Minnesota (155)
Mississippi (1)
Missouri (52)
Montana (16)
Nebraska (10)
Nevada (23)
New Hampshire (23)
New Jersey (1067)
New Mexico (26)
New York (1088)
North Carolina (605)
North Dakota (5)
Northern California (1428)
Ohio (119)
Oklahoma (6)
Oregon (14)
Pennsylvania (674)
Puerto Rico (2)
Rhode Island (17)
South America (587)
South Carolina (11)
Southern California (1237)
Tennessee (41)
Texas (501)
Utah (86)
Virginia (87)
Washington D.C. (45)
Washington State (360)
West Virginia (1)
Wisconsin (30)
393,414 Results for "prism research".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
PRISM BioLab, enters into a Joint Research and Licensing Agreement with Ono
PRISM BioLab, Co. Ltd. announced that it has entered into a target-exclusive research and licensing agreement with ONO PHARMACEUTICAL CO., LTD.
April 25, 2024
·
3 min read
FDA
ClearPoint Neuro Announces FDA Clearance of Prism Bone Anchor Accessory
ClearPoint Neuro, Inc. today announced it has received 510(k) clearance for its Prism Bone Anchor Accessory.
April 29, 2024
·
4 min read
Press Releases
Cardiol Therapeutics Inc. Added to PRISM Emerging Biotech Index
November 13, 2024
·
4 min read
Policy
Setting the Stage for Success: PRISM MarketView Highlights Soligenix’s Promising HyBryte™ Replication Trial
PRISM MarketView, a leader within the financial markets and news community, announces the release of an article highlighting Soligenix Inc’s (Nasdaq: SNGX) key achievements and pathway to regulatory success through its lead product candidate, HyBryte™ (synthetic hypericin) for the treatment of cutaneous T-cell lymphoma, a rare and chronic cancer.
June 5, 2024
·
8 min read
Biotech Beach
ClearPoint Neuro Announces Full Market Release of SmartFrame OR™ and ClearPoint PRISM® 3T Laser Therapy System
ClearPoint Neuro, Inc. announces full market release of its SmartFrame OR platform and ClearPoint Prism Neuro Laser Therapy System at the 2024 Biennial Meeting of the American Society of Stereotactic and Functional Neurosurgery from Saturday, June 1st – Tuesday, June 4th in Nashville.
June 1, 2024
·
5 min read
Press Releases
4DMT Announces Corporate Webcast to Review Interim 52-week Results from the Phase 2b Cohort of PRISM in a Broad Wet AMD Population
January 30, 2025
·
4 min read
Press Releases
Aclarion Added to PRISM Emerging Medical Devices Index
September 6, 2024
·
4 min read
Press Releases
4DMT Presents Positive 52-Week Results from Phase 2b Cohort of PRISM Wet AMD Study and Long-term Durability Data Supporting 4D-150 4FRONT Global Registration Program
February 9, 2025
·
9 min read
Business
PRISM BioLab and Lilly Enter into a Drug Discovery Collaboration on a Protein-Protein Interaction Target
PRISM BioLab, Co. Ltd. (“PRISM”), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a License and Collaboration Agreement with Eli Lilly and Company (“Lilly”).
November 28, 2023
·
2 min read
Biotech Bay
4DMT to Present Initial Interim 24-week Landmark Analysis from the 4D-150 Phase 2 PRISM Population Extension Cohort in a Broad Wet AMD Population at ASRS and Host a Corporate Webcast
4D Molecular Therapeutics today announced that the Company will present the initial interim 24-week landmark analysis from the Population Extension cohort of the PRISM Phase 2 Clinical Trial evaluating 4D-150 in a broad wet AMD patient population at the ASRS Annual Scientific Meeting being held in Stockholm, Sweden from July 17-20, 2024.
June 18, 2024
·
3 min read
1 of 39,342
Next
